Diagnostic tests for anti-endotoxin core antibodies
OwnerDaniel P. Rossignol, Melvyn Lynninventors
Life of this patent
Estimating the term…
Abstract
The invention provides methods and kits for determining whether a patient may benefit from treatment with an anti-endotoxin compound.
Claims13
A method of determining whether a patient could benefit from treatment with an anti-endotoxin compound, said method comprising obtaining a sample from a patient and determining the level of anti-endotoxin core antibodies in the sample.
A kit for use in determining whether a patient could benefit from treatment with an anti-endotoxin compound, said kit comprising (i) a solid substrate comprising an endotoxin from a gram-negative bacterium, and (ii) instructions stating what level of anti-endotoxin core antibodies detected by use of the kit indicates that the patient could benefit from treatment with an anti-endotoxin compound.
A method of treating a patient that has or is at risk of developing a condition that is treatable by the use of an anti-endotoxin compound, said method comprising the steps of (i) determining the level of anti-endotoxin core antibodies in a sample from the patient, and, if the levels of anti-endotoxin core antibodies in the sample are inadequate, (ii) administering an antiendotoxin compound to the patient.
Dependencies are inferred from the claim text.